Table 1.
Baseline characteristics of the patients.
| Overall (n = 617) | BCL2 low (n = 97) | BCL2 high (n = 520) | p value | |
|---|---|---|---|---|
| Mean age ± deviation, yr | 54.8 ± 11.22 | 52.86 ± 11.62 | 55.15 ± 11.12 | 0.65 |
| Mean tumor size ± standard deviation, cm | 2.17 ± 1.49 | 2.09 ± 1.21 | 2.19 ± 1.53 | 0.58 |
| Nodal disease (n, %) | 0.054 | |||
| Negative | 432(70) | 76(78.4) | 356(68.5) | |
| Positive | 185(30) | 21(21.6%) | 164(31.5) | |
| ER (n, %) | 0.012 | |||
| Positive | 425(68.9) | 56(57.7) | 369(71.0) | |
| Negative | 192(31.1) | 41(42.3) | 151(29.0) | |
| PR (n, %) | 0.573 | |||
| Positive | 368(59.6) | 42(43.4) | 207(39.8) | |
| Negative | 249(40.4) | 55(56.7) | 313(60.2) | |
| HER2 (n, %) | < 0.001 | |||
| Negative | 458(74.2) | 55(56.7) | 403(77.5) | |
| Positive | 158(25.6) | 42(43.3) | 116(22.3) | |
| Missing | 1(0.2) | 0 | 1(0.2) |